AMLN Amylin Pharmaceuticals, Inc. (MM)

Amylin Pharmaceuticals to Webcast Third Quarter Results SAN DIEGO, Oct. 26 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. (NASDAQ:AMLN) will webcast its Quarterly Update Conference Call for the third quarter on Tuesday, November 2, 2004 at 12:00 p.m. Eastern/9:00 a.m. Pacific. The call will be led by Ginger L. Graham, Amylin's President and Chief Executive Officer. On the same date, Amylin will release financial results for the third quarter of 2004 prior to the market open. The call will be webcast live through Amylin's corporate website, and a recording will be made available following the close of the call. To access the webcast, please log on to http://www.amylin.com/ approximately fifteen minutes prior to the call to register, download and install any necessary audio software. A recording will be available by phone for 24 hours beginning approximately one hour after the close of the call and can be accessed at 888-286-8010 (domestic) or 617-801-6888 (international), passcode 48865049. Amylin Pharmaceuticals is committed to improving the lives of people with diabetes and other metabolic diseases through the discovery, development, and commercialization of innovative, cost-effective medicines. DATASOURCE: Amylin Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of Finance and Chief Financial Officer of Amylin Pharmaceuticals, +1-858-552-2200 Web site: http://www.amylin.com/

Copyright